- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: Legal American Sales to Reach US$45 Billion by 2027
The cannabis industry received some good news this week — a new report is projecting significant sales growth in the next decade for the US market.
A new report from a leading analytics firm shows the cannabis industry will reach US$45 billion in legal sales by 2027.
Meanwhile, a critical vote on a banking reform bill designed to help the US cannabis industry could see a vote in the Senate in a few weeks. Keep reading to find out more cannabis highlights from the past five days.
Legal sales set to take off in US market
Cannabis research firm BDSA is projecting tremendous growth for the legal US cannabis industry in the near future.
Roy Bingham, co-founder and CEO of BDSA, pointed to new adult-use markets in Missouri, New Jersey and New York as leaders for growth. “Over the next five years, the biggest drivers of cannabis industry growth in the U.S. will be the thriving Midwest and East Coast markets,” he said in a press release introducing the report.
As far as 2023 goes, BDSA is projecting US$29.6 billion from sales in the US legal market. On a global scale, the research firm is expecting to see a total tally of US$36.7 billion.
Vote for banking reform bill gets nearer
According to Senate Banking Committee Chairman Sherrod Brown, “in the next two or three weeks” a vote could take place regarding a revamped cannabis banking reform bill.
The bill has been touted as a chance to adjust the financial realities of the current cannabis landscape.
As per a report from Marijuana Moment, the senator did not provide a timeline for a vote.
Cannabis company news
- Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF)filed for creditor protection under the Companies' Creditors Arrangement Act (CCAA). The company indicated to investors that after an extensive review of its operations, the best course of action is to apply for creditor protection under the CCAA.
- It was confirmed this past trading week that Canadian cannabis producer Canopy Growth (NASDAQ:CGC,TSX:WEED) will be removed from the S&P/TSX Composite Index (INDEXTSI:OSPTX) before the markets open on June 19.
- SNDL (NASDAQ:SNDL)appointed Alberto Paredero-Quiros as its new CFO, replacing Jim Keough, who served the company for five years.
- TerrAscend (CSE:TER,OTCQX:TRSSF)announced an agreement to acquire a medical dispensary in the state of Maryland. The transaction is worth US$22.1 million. “With less than 30 days until the launch of adult use in Maryland, we are focused on additional acquisitions and reaching the four-dispensary cap as our northeast business unit will soon be operating in Maryland under the same successful business model we built in NJ,” Jason Wild, executive chairman of TerrAscend, said.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.